Find support for everystep of your treatment, including how to access REZLIDHIA, copay assistance, patient support services, and additional resources
RIGEL ONECARE is here to support you along your treatment journey with REZLIDHIA*
Nurse Navigation
Reimbursement Specialists
Financial and Copay Assistance
Nurses at RIGEL ONECARE are fully trained to support you and will:
- Connect with your insurance plan and your healthcare providers to understand your coverage
- Determine if you qualify and help you enroll in copay and financial assistance programs
- Answer any questions you may have during your treatment with REZLIDHIA
- Be ready and available Monday-Friday 8 AM to 8 PM ET to address any questions or concerns
All RIGEL ONECARE programs are subject to eligibility requirements and changes. Criteria above do not represent all criteria for each program.
Must be U.S. resident or U.S. territory resident. Restrictions apply.
REZLIDHIA financial assistance
Eligible patients with commercial insurance pay as little as $15 per prescription fill with the REZLIDHIA copay assistance program.†
- Fill out and submit your information to determine if you are eligible
- Print out the copay card and have it available when speaking with the specialty pharmacy
All RIGEL ONECARE programs are subject to eligibility requirements and changes. Criteria above do not represent all criteria for each program. Must be U.S. resident or U.S. territory resident. Restrictions apply.
Additional REZLIDHIA resources
Visit REZLIDHIA.com for additional resources to help guide and support you or the person you care for during treatment with REZLIDHIA
Patient Education Guide
A helpful guide about what to expect when starting treatment with REZLIDHIA
Patient Medication Guide
A guide with instructions on how to take REZLIDHIA, the possible side effects, proper storage, and more
Differentiation Syndrome Pocket Card
A card to carry with you and share with healthcare providers or emergency responders should you have signs and symptoms of differentiation syndrome
Foundations with financial assistance
The following groups may be able to give you additional help with paying for your AML treatment
What is REZLIDHIA?
REZLIDHIA is a prescription medicine used to treat adults with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-1 (IDH1) mutation when the disease has come back or has not improved after previous treatment(s).
Your healthcare provider will perform a test to make sure that REZLIDHIA is right for you.
It is not known if REZLIDHIA is safe and effective in children.
IMPORTANT SAFETY INFORMATION
REZLIDHIA may cause serious side effects including:
- Differentiation Syndrome. Differentiation syndrome is a condition that affects your blood cells and may be life-threatening or lead to death. Differentiation syndrome in adults with acute myeloid leukemia (AML) has occurred as early as 1 day and up to 18 months after starting REZLIDHIA. Call your healthcare provider or go to the nearest hospital emergency room right away if you develop any of the following symptoms of differentiation syndrome during treatment with REZLIDHIA:
- fever
- cough
- trouble breathing
- decreased urination
- dizziness or lightheadedness
- weight gain
- swelling of your arms or legs
- Liver problems. Changes in liver function tests are common during treatment with REZLIDHIA and can be serious. Your healthcare provider will do blood tests to check your liver function before and during treatment with REZLIDHIA. Tell your healthcare provider right away if you develop any of the following symptoms of liver problems during treatment with REZLIDHIA:
- yellowing of your skin or the white part of your eyes (jaundice)
- dark “tea-colored” urine
- loss of appetite
- pain on the upper right side of your stomach area
- feeling very tired or weak
The most common side effects of REZLIDHIA in adults with AML include:
- abnormal liver function tests
- nausea
- feeling tired or unwell
- joint pain
- constipation
- shortness of breath
- fever
- rash
- mouth sores
- diarrhea
- changes in certain blood tests
Tell your healthcare provider if you have any nausea, constipation, diarrhea, vomiting, stomach pain or mouth sores.
Your healthcare provider will do blood tests before you start and during treatment with REZLIDHIA. Your healthcare provider may decrease, temporarily hold, or permanently stop your treatment with REZLIDHIA if you develop certain side effects. These are not all the possible side effects of REZLIDHIA.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1‑800‑FDA‑1088.
Before taking REZLIDHIA, tell your healthcare provider about all of your medical conditions, including if you:
- have liver problems.
- are pregnant or plan to become pregnant. REZLIDHIA may harm your unborn baby.
- are breastfeeding or plan to breastfeed. It is not known if REZLIDHIA passes into your breast milk. Do not breastfeed during your treatment with REZLIDHIA and for 2 weeks after your last dose of REZLIDHIA.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Click here for Full Prescribing Information, including Boxed WARNING and Medication Guide.
BACK TO TOP
Product questions or medical inquiries?
Please send any medical inquiries and report complaints or adverse events to: Rigel Medical Communications Center at 1‑800-983-1329 or producthelp@rigel.com
You may also report report adverse events associated with taking our prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800-FDA-1088 (1-800-332-1088).
Call 1-833-RigelOC (1-833-744-3562) Monday-Friday 8 AM to 8 PM ET to contact RIGEL ONECARE